UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported):  September 26, 2016
 
AgroFresh Solutions, Inc.
(Exact Name of Registrant as Specified in Charter)
 
Delaware
 (State or other jurisdiction
of incorporation)
 
001-36316
 (Commission File Number)
 
46-4007249
 (I.R.S. Employer
Identification Number)
 
One Washington Square 510-530 Walnut Street, Suite 1350
Philadelphia, PA
(Address of principal executive offices)
 
19106
(Zip code)
 
(267) 317-9139

(Registrant’s telephone number, including area code)
 
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
 
o                          Written communications pursuant to Rule 425 under the Securities Act
 
o                          Soliciting material pursuant to Rule 14a-12 under the Exchange Act
 
o                          Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
 
o                          Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act








Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
 
On September 26, 2016, AgroFresh Solutions, Inc. (the “Company”) appointed Katherine Harper as Chief Financial Officer of the Company, to be effective on October 3, 2016 (the “Effective Date”), replacing Margaret M. Loebl, whose service with the Company, including as Chief Financial Office and Executive Vice President, ended on September 26.
 
Ms. Harper, age 53, served as Chief Financial Officer of Tronox Limited (“Tronox”) from September 2013 until September 2016. Prior to joining Tronox, Ms. Harper served as the chief financial and business development officer of Rio Tinto’s diamonds and minerals group. She previously held finance and business transformation roles in Rio Tinto’s mining and alternative energy units. Earlier in her career she worked for 12 years in senior finance posts with the Gulbrandsen Group, a privately held chemical manufacturing company, and the General Chemical Corporation. She began her career as a financial analyst within the power systems group of the Westinghouse Electric Corporation. Ms. Harper holds Bachelor of Science and Master of Business Administration degrees from Carnegie Mellon University.
 
In connection with her appointment, Ms. Harper entered into an employment agreement, executed on September 26, 2016 and dated as of September 26, 2016 (the “Employment Agreement”), with the Company. Pursuant to the Employment Agreement, Ms. Harper will serve as Chief Financial Officer of the Company, reporting to the Chief Executive Officer, for an initial term of three years commencing on the Effective Date, with automatic successive one-year renewal terms thereafter unless either party gives notice of non-renewal 30 days prior to the end of the then-current term.
 
Ms. Harper will receive an initial base salary of $450,000 per year, subject to annual reviews and potential increases, in the discretion of the compensation committee of the Company’s board of directors (the “Compensation Committee”). Ms. Harper will receive a one-time bonus of $50,000, payable 90 days following the Effective Date, provided that she is employed by the Company on the date due. Ms. Harper will also be entitled to an annual bonus for each full fiscal year during her employment term, with a target bonus amount equal to 70% of her annual base salary, subject to the achievement of performance objectives to be established by the Compensation Committee each year. For 2016, Ms. Harper’s annual bonus would be pro-rated based on the portion of the year that Ms. Harper is employed by the Company.

Pursuant to the Employment Agreement, Ms. Harper will be entitled to receive grants of equity awards under the Company’s 2015 Incentive Compensation Plan (the “Plan”) consisting of (i) shares of restricted stock having a value of $400,000 based on the Company’s closing stock price on the date of grant (the “Closing Stock Price”), and (ii) nonqualified stock options to purchase that number of shares of the Company’s common stock equal to $400,000 divided by the Closing Stock Price, at an exercise price equal to the Closing Stock Price, in each case subject to vesting in three equal annual installments following the commencement of employment. In addition, commencing in 2016 and in each successive year of Ms. Harper’s employment, she will be entitled to receive equity awards having a total target value equal to 150% of her base salary on the date of grant. For purposes of the Employment Agreement, the “total target value” of any equity award shall be calculated (i) in the case of restricted stock awards, as the Fair Market Value (as defined in the Equity Plan) of the Company’s common stock on the date of grant multiplied by the number of shares of restricted stock awarded, and (ii) in the case of stock option awards, as the Fair Market Value of the Company's common stock on the date of grant multiplied by the number of shares of stock issuable upon exercise of such options (and any such stock options will have an exercise price no less than the Company's closing stock price on the date of grant).





 
If Ms. Harper’s employment under the Employment Agreement is terminated by the Company without “Cause” or by Ms. Harper for “Good Reason” (as such terms are defined in the Employment Agreement), or if the Company elects not to extend the term of employment under the Employment Agreement beyond the then-current term, the Company will be obligated to pay to Ms. Harper (i) all accrued but unpaid salary and benefits, (ii) an amount equal to 1.5 times her base salary then in effect (unless termination occurs within 12 months of the Effective Date, in which case the amount would be equal to 1.0 times her base salary then in effect), payable in equal installments over a 12-month period, and (iii) if Ms. Harper elects continued “COBRA” health care coverage for herself or her eligible dependents, an amount equal to the difference between the premium paid for such COBRA coverage and the premium charged by the Company to an active employee for comparable coverage, payable over a 12-month period (or such shorter period as Ms. Harper elects to receive COBRA coverage). The Company’s obligation to pay any of the foregoing severance obligations (other than salary and benefits accrued through the date of termination of employment) would be subject to Ms. Harper’s execution of a release of all claims against the Company, and such release having become irrevocable.
 
The Employment Agreement contains customary confidentiality provisions, which apply both during and after the term of the Employment Agreement, and customary non-competition and non-solicitation provisions, which apply during the term of the Employment Agreement and for 18 months thereafter.

Item 8.01 Other Events.

On September 27, 2016, the Company issued a press release regarding the management changes described above. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01 Exhibits

(d) Exhibits.
 
Exhibit
Number
 
Exhibit
 
 
 
10.1
 
Employment Agreement, dated as of September 23, 2016, between the Company and Katherine Harper.
99.1
 
Press Release issued by the Company on September 27, 2016.







SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
 
Dated: September 30, 2016
 
 
AGROFRESH SOLUTIONS, INC.
 
 
 
By:
/s/ Thomas Ermi
 
 
Name: Thomas Ermi
 
 
Title: Vice President and General Counsel






EXHIBIT INDEX

Exhibit
Number
 
Exhibit
 
 
 
10.1
 
Employment Agreement, dated as of September 23, 2016, between the Company and Katherine Harper.
99.1
 
Press Release issued by the Company on September 27, 2016.





EMPLOYMENT AGREEMENT
KATHERINE HARPER
EMPLOYMENT AGREEMENT (the “ Agreement ”) dated as of September 23, 2016 by and between AgroFresh Solutions, Inc. (the “ Company ”) and Katherine Harper (“ Executive ”).
NOW THEREFORE, in consideration of the premises and mutual covenants herein and for other good and valuable consideration, the parties agree as follows:
1. Term of Employment . Subject to the provisions of Section 7 of this Agreement, Executive shall be employed by the Company for a period commencing on October 3, 2016, or such other date as may be mutually agreed upon by the Company and Executive (the “ Effective Date ”), and ending on the day before the third anniversary of the Effective Date (the “ Employment Term ”) on the terms and subject to the conditions set forth in this Agreement; provided, however, that commencing with the third anniversary of the Effective Date and on each anniversary thereafter (each an “ Extension Date ”), the Employment Term shall be automatically extended for an additional one-year period, unless the Company or Executive provides the other party hereto 30 days prior written notice before the next Extension Date that the Employment Term shall not be so extended.
2. Position .
a. During the Employment Term, Executive shall serve as Chief Financial Officer of the Company and will report to the Chief Executive Officer of the Company. In such position, Executive shall have the duties and authority commensurate with the position as shall be determined from time to time by the Chief Executive Officer of the Company or the Board of Directors of the Company (the “ Board ”).
b. During the Employment Term, Executive will devote her full business time and best efforts, in accordance with legal and regulatory requirements, to the performance of Executive’s duties hereunder and will not engage in any other business, profession or occupation for compensation or otherwise, including without limitation service on any board of directors or trustees of any business corporation or charitable organization, without the prior written consent of the Board.
3. Base Salary and Signing Bonus .
a. During the Employment Term, the Company shall pay Executive a base salary (the “ Base Salary ”) at the annual rate of not less than $450,000, payable in regular installments in accordance with the Company’s usual payment practices. Executive shall be entitled to annual reviews and increases in Executive’s Base Salary, if any, as may be determined in the sole discretion of the Compensation Committee. The Executive’s Base Salary may not be decreased at any time during the Employment Term.
b. Executive shall receive a one-time signing bonus in the gross amount of $50,000, payable ninety (90) days following the Effective Date, provided she is in the employ of the Company on the date that payment is due.
4. Incentive Compensation .
a. With respect to each full fiscal year during the Employment Term, Executive shall be eligible to earn an annual bonus award (an “ Annual Bonus ”) payable in cash with a target amount equal to 70% of Executive’s Base Salary (the “ Target ”), based upon the achievement of performance objectives established by the Compensation Committee each year. For calendar year 2016, the Annual Bonus shall be prorated, based upon the portion of the year that Executive is employed by the Company. The “fiscal year” during the Employment Term shall be equal to the calendar year unless otherwise established by the Board in consultation with Executive. The performance objectives for payment of the Annual Bonus shall be established in writing by the Compensation Committee, on or before the end of the third month of the applicable fiscal year and shall include performance metrics which enable the Executive to earn up to two times the Target in the event certain performance conditions are met. Any Annual Bonus earned for any calendar year shall be paid within the first 2 ½ months of the immediately following calendar year.
b. The Company has adopted an equity incentive plan reserving 2,750,000 shares of common stock of the Company (the “ Equity Plan ”). As soon as reasonably practicable following the Effective Date (the “ Grant Date ”), the Company shall grant the Executive awards (collectively, the “ Equity Award ”) under the Equity Plan, consisting of (i) restricted stock (“ Restricted Stock ”) having a value of $400,000 based on the Fair Market Value (as defined in the Equity Plan) of the Company’s common stock on the Grant Date and (ii) nonqualified stock options (“ Options ”) with respect to that number of shares of the Company’s common stock equal to $400,000 divided by the Fair Market Value of the Company’s common stock on the Grant Date, with an exercise price per share equal to such Fair Market Value. The vesting schedule for the Restricted Stock and Options subject to the Equity Award shall be as follows: 100% of the Options and the Restricted Stock subject to the Equity Award shall vest over three (3) years in three equal installments on each anniversary of the Grant Date, beginning on the first anniversary of the Grant Date; provided that Executive’s employment with the Company continues through and on the applicable vesting date. The Restricted Stock and Options subject to the Equity Award shall be subject to such other terms as set forth in the applicable grant agreements and in the underlying Equity Plan.
c. The Compensation Committee will establish a long-term incentive plan for executives and other key employees in 2017 (the “ 2017 LTI Plan ”). The Executive shall be entitled to receive equity awards having a total target value equal to 150% of the Base Salary as of the date of grant pursuant to the 2017 LTI Plan, allocated among stock options, shares of restricted stock subject to time-based vesting, and shares of restricted stock subject to performance-based vesting, based on the overall terms of and subject to the conditions to be set forth in the 2017 LTI Plan, as determined by the Compensation Committee. In successive years during the Employment Term, the Executive shall be eligible for additional grants of restricted stock, stock options and any other forms of incentive compensation during the Employment Term, with the aggregate grant date target value of each of such grants to be 150% of the Base Salary as of the date of grant. For purposes hereof, the “total target value” of any equity award shall be calculated as the Fair Market Value (as defined in the Equity Plan) of the Company’s common stock on the date of grant multiplied by the number of shares of stock subject to the equity award (including, in the case of stock options, the number of shares of stock issuable upon exercise of such options).
d. The Company may (i) cause the cancellation of the Equity Award or any additional grants of restricted stock, options and any other forms of incentive compensation during the Employment Term, (ii) require reimbursement of the Equity Award or any additional grants of restricted stock, options and any other forms of incentive compensation during the Employment Term, and (iii) effect any other right of recoupment of equity or other compensation provided under this Agreement or otherwise, in all respects as to subclauses (i), (ii) and (iii) hereof, as required by and in accordance with applicable law.
5. Employee Benefits .
a. General . During the Employment Term, Executive shall be entitled to participate in the Company’s employee benefit plans, as amended from time to time, as in effect from time to time, including disability benefits (collectively “ Employee Benefits ”), on the same basis as those benefits are generally made available to other senior executives of the Company.
b. Life Insurance . During the Employment Term, the Company will provide Executive life insurance covering at least four times her Base Salary.
c. Tax Preparation and Financial Planning Expenses . During the Employment Term, the Company shall reimburse the Executive up to $15,000 per calendar year for annual tax preparation and financial planning expenses.
6. Business Expenses . During the Employment Term, reasonable business expenses incurred by Executive in the performance of Executive’s duties hereunder shall be reimbursed by the Company in accordance with Company policies.
7. Termination . The Employment Term and Executive’s employment hereunder may be terminated by either party at any time and for any reason; provided that Executive will be required to give the Company at least 60 days advance written notice of any resignation of Executive’s employment, subject to and in accordance with the provisions of this Section 7. Notwithstanding any other provision of this Agreement, subject to Sections 8, 9, 10, 11(f), 11(j), 11(m) and 11(o), the provisions of this Section 7 shall exclusively govern Executive’s and the Company’s rights and obligations related to termination of this Agreement and the rights and remedies upon termination of employment with the Company and its affiliates.
a. By the Company For Cause or Resignation by the Executive without Good Reason .
(i)      The Employment Term and Executive’s employment hereunder may be terminated by the Company for “Cause” (as defined below) and shall terminate automatically upon Executive’s resignation without “Good Reason” (as defined below), provided that Executive will be required to give the Company at least 60 days advance written notice of any such resignation, and provided further that the Company may elect to waive such notice period and to pay Executive in lieu of such notice.

(i) For purposes of this Agreement “Cause” shall mean (A) Executive’s continued failure to substantially perform Executive’s duties hereunder (other than as a result of total or partial incapacity due to physical or mental illness) for a period of 30 days following written notice by the Company to Executive of such failure; provided that it is understood that this clause (A) shall not permit the Company to terminate Executive’s employment for Cause because of dissatisfaction with the quality of services provided by or disagreement with the actions taken by Executive in the good faith performance of Executive’s duties to the Company, (B) theft or embezzlement of Company property, (C) Executive’s conviction of or plea of guilty or no contest to (x) a felony or (y) a crime involving moral turpitude, (D) Executive’s willful malfeasance or willful misconduct in connection with Executive’s duties hereunder or any act or omission taken in bad faith which is materially injurious to the financial condition or business reputation of the Company or any of its subsidiaries or affiliates, or (E) Executive’s material breach of any provisions of this Agreement.
(ii) If Executive’s employment is terminated by the Company for Cause, or if Executive resigns without Good Reason, Executive shall be entitled to receive, within 30 days following such termination with respect to (A)-(C) below, and at such time, if any, as the Employee Benefits under (D) below become due in accordance with the applicable terms thereof:
(A) the Base Salary earned ratably through the date of termination, to the extent not already paid;
(B) any Annual Bonus earned but unpaid as of the date of termination for any previously completed fiscal year;
(C) reimbursement for any unreimbursed business expenses properly incurred by Executive in accordance with the Company policy prior to the date of Executive’s termination; and
(D) such vested Employee Benefits, if any, as to which Executive may be entitled under the employee benefit plans of the Company as described in Section 5(a) (including, without limitation, any retirement benefits, medical, life insurance or disability benefits, accrued but unpaid vacation or other benefits Executive is entitled to pursuant to the terms of the applicable plans then in effect (the amounts described in clauses (A) through (D) hereof being referred to as the “ Accrued Obligations ”).
Following such termination of Executive’s employment by the Company for Cause or resignation by Executive without Good Reason, except as set forth in this Section 7(a)(iii), Executive shall have no further rights to any compensation or any other benefits in the nature of severance or termination pay or in connection with the termination of her employment. Notwithstanding the foregoing, nothing in this Section 7(a) shall affect the Executive’s right to any vested benefits under any employee benefit plans sponsored by the Company, including but not limited to any retirement plans.
b.      Disability or Death .
(i)      The Employment Term and Executive’s employment hereunder shall terminate upon Executive’s death and may be terminated by the Company if Executive becomes physically or mentally incapacitated and is therefore unable for a period of six (6) consecutive months or for an aggregate of nine (9) months in any twenty-four (24) consecutive month period to perform Executive’s duties (such incapacity is hereinafter referred to as “ Disability ”); provided that a termination on the basis of a Disability must occur within 90 days of the date when Executive is subject to termination due to Disability. Any question as to the existence of the Disability of Executive as to which Executive and the Company cannot agree shall be determined in writing by a qualified independent physician mutually acceptable to Executive and the Company. If Executive and the Company cannot agree as to a qualified independent physician, each shall appoint such a physician and those two physicians shall select a third physician and it shall be the responsibility of such third physician to make such determination in writing. The determination of Disability made in writing to the Company and Executive shall be final and conclusive for all purposes of the Agreement.
(ii)      Upon termination of Executive’s employment hereunder for either Disability or death, Executive or Executive’s estate (as the case may be) shall be entitled to receive, at the times set forth in Section 7(a)(iii) hereof, the Accrued Obligations.
Following Executive’s termination of employment due to death or Disability, except as set forth in this Section 7(b)(ii), Executive shall have no further rights to any compensation or any other benefits in the nature of severance or termination pay or in connection with the termination of her employment. Notwithstanding the foregoing, nothing in this Section 7(b) shall affect the Executive’s right to any vested benefits under any employee benefit plans sponsored by the Company, including but not limited to any retirement plans.
c.      By the Company Without Cause or Resignation by Executive for Good Reason .
(i) The Employment Term and Executive’s employment hereunder may be terminated by the Company without Cause or by Executive’s resignation for Good Reason.
(ii) If Executive’s employment is terminated by the Company without Cause (other than by reason of death or Disability) or by Executive’s resignation for Good Reason, and subject to the conditions described below, Executive shall be entitled to receive:
(A) At the times set forth in Section 7(a)(iii) hereof, the Accrued Obligations;
(B) payment of an amount equal to 1.5 times the Base Salary in effect at the time of termination (except that in the event of termination within twelve (12) months of the Effective Date, such payment amount shall be equal to 1.0 times the Base Salary then in effect), payable, in equal installments in accordance with regular payroll procedures established by the Company, over a twelve month period beginning with the first payroll date that occurs on or after the sixtieth (60 th ) day following the date on which the Employment Term and Executive’s employment hereunder terminated; and
(C) if Executive elects continued coverage for herself or her eligible dependents under any of the Company’s health plans pursuant to Section 4980B of the Internal Revenue Code of 1986, as amended (the “ Code ”) or any comparable law (“ COBRA ”), for each month during which such coverage is in effect (but not more than twelve (12) months), an amount equal to the difference between the premium paid for such COBRA coverage and the premium charged by the Company to an active employee for comparable coverage, which monthly amount shall be payable over a 12 month period (or shorter period to the extent the Executive elects COBRA coverage for less than 12 months), beginning with the first payroll date that occurs on or after the sixtieth (60 th ) day following the date on which the Employment Term and Executive’s employment hereunder terminated.
(iii)      For purposes of this Agreement, “Good Reason” shall mean (A) a failure of the Company to pay or cause to be paid Executive’s Base Salary or Annual Bonus (if any) when due, (B) a reduction in Executive’s Base Salary or the Target for her Annual Bonus opportunity described in Section 4 herein, (C) a relocation of Executive’s primary work location of more than 50 miles from the work location on the Effective Date, without written consent of Executive, or (D) a material reduction or modification in Executive’s duties, responsibilities or reporting structure as described in Section 2(a) of this Agreement; provided that none of these events shall constitute Good Reason unless (1) the Executive provides the Company with written notice of the existence of such condition within 30 days after the initial existence of the condition, (2) the Company fails to remedy the condition within 30 days after its receipt of such notice and (3) the Executive resigns within 30 days after the expiration of such 30-day remedy period.
The payments and benefits described in subparagraphs 7(c)(ii)(B) - (C) above shall be subject to and conditioned upon (1) Executive’s execution and delivery of a valid and effective general release and waiver in such form as reasonably provided by the Company, containing standard and customary terms not inconsistent with the terms of this Agreement, to effectuate a valid release of claims (exempting any claims to enforce Executive’s rights under this Agreement) that becomes irrevocable within sixty (60) days of the date on which the Employment Term and Executive’s employment hereunder terminates; and (2) Executive’s continued compliance with her obligations under Sections 8 and 9 of this Agreement. Following Executive’s termination of employment by the Company without Cause (other than by reason of Executive’s death or Disability) or by Executive’s resignation for Good Reason, except as set forth in Section 7(c)(ii), and subject to Section 7(e) below, Executive shall have no further rights to any compensation or any other benefits in the nature of severance or termination pay or in connection with the termination of her employment. Notwithstanding the foregoing, nothing in this Section 7(c) shall affect the Executive’s right to any vested benefits under any employee benefit plans sponsored by the Company, including but not limited to any retirement plans.
d. Election Not to Extend the Employment Term . In the event either party elects not to extend the Employment Term by providing thirty (30) days’ written notice prior to the end of the then-current term pursuant to Section 1, unless Executive’s employment is earlier terminated pursuant to paragraphs (a), (b) or (c) of this Section 7, Executive’s termination of employment hereunder (whether or not Executive continues as an employee of the Company thereafter) shall be deemed to occur on the close of business on the day immediately preceding the next scheduled Extension Date. If Executive’s employment is terminated following Executive’s election not to extend the Employment Term, Executive shall be entitled to receive the Accrued Obligations. If the Company elects not to extend the Employment Term, Executive shall be entitled to receive the severance payments and benefits set forth in Section 7(c). The payments and benefits described in this Section 7(d) shall be subject to and conditioned upon (1) Executive’s execution and delivery of a valid and effective general release and waiver, in such form as reasonably provided by the Company to effectuate a valid release of claims (exempting any claims to enforce Executive’s rights under this Agreement) that becomes irrevocable within sixty (60) days of the date on which the Employment Term and Executive’s employment hereunder terminates; and (2) Executive’s continued compliance with her obligations under Sections 8 and 9 of this Agreement. Following such termination of Executive’s employment hereunder as a result of either party’s election not to extend the Employment Term, except as set forth in this Section 7(d), Executive shall have no further rights to any compensation or any other benefits in the nature of severance or termination pay or in connection with the termination of her employment. Notwithstanding the foregoing, nothing in this Section 7(d) shall affect the Executive’s right to any vested benefits under any employee benefit plans sponsored by the Company, including, but not limited to, any retirement plans.
e. Notice of Termination. Any purported termination of employment by the Company or by Executive (other than due to Executive’s death) shall be communicated by written Notice of Termination to the other party hereto in accordance with Section 11(g) hereof. For purposes of this Agreement, a “Notice of Termination” shall mean a notice which shall indicate the specific termination provision in this Agreement relied upon and shall set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of employment under the provision so indicated.
f. Continuing Rights Under Equity Plan. Notwithstanding anything herein to the contrary, upon a termination of employment, Executive’s rights and obligations post-termination with respect to awards made under the Equity Plan shall be determined in accordance with the Equity Plan and Section 4 hereof.
g. Parachute Payments . Notwithstanding any other provision of this Agreement to the contrary, to the extent that any payment or distribution of any type to or for the Executive by the Company (or by any affiliate of the Company, any person or entity who acquires ownership or effective control of the Company or ownership of a substantial portion of the Company’s assets (within the meaning of Section 280G of the Code and the regulations thereunder)), or any affiliate of such person or entity, whether paid or payable or distributed or distributable pursuant to the terms of this Agreement or otherwise (the “ Total Payments ”), is or will be subject to the excise tax imposed under Section 4999 of the Code (the “ Excise Tax ”), then the Total Payments shall be reduced (but not below zero) if and to the extent that a reduction in the Total Payments would result in the Executive’s retaining a larger amount, on an after-tax basis (taking into account federal, state and local income taxes and the Excise Tax), than if the Executive received the entire amount of such Total Payments. The determination of whether the Total Payments shall be reduced and the amount of such reduction shall be determined by an accounting firm selected by the Executive and the Company (which accounting firm’s fees shall be paid for by the Company), and shall be final and binding upon the Executive and the Company. The accounting firm’s decision as to which of the Total Payments are to be reduced, if any, shall be made (A) only from the Total Payments that the accounting firm determines reasonably may be characterized as “parachute payments” under Section 280G of the Code; (B) only from the Total Payments that are required to be made in cash, (C) only with respect to any amounts that are not payable pursuant to a “nonqualified deferred compensation plan” subject to Section 409A of the Code, until those payments have been reduced to zero, and (D) in reverse chronological order, to the extent that any of the Total Payments subject to reduction are made over time (e.g., in installments). In no event, however, shall any of the Total Payments be reduced if and to the extent such reduction would cause a violation of Section 409A of the Code or other applicable law.
8. Non-Competition.
a. Executive acknowledges and recognizes the highly competitive nature of the businesses of the Company and accordingly agrees as follows:
(i)      During her employment with the Company and for a period of 18 months following the date Executive ceases to be employed by the Company (the “ Restricted Period ”), Executive will not, whether on Executive’s own behalf or on behalf of or in conjunction with any person, company, business entity or other organization engaged in a Competitive Business (as defined below), directly or indirectly, solicit or assist in soliciting any business related to a Competitive Business from any client or prospective client of the Company or any of its affiliates.
(ii)      During the Restricted Period and within the Continents of North America, South America, Africa, Europe, Asia, and Australia (the “ Restricted Territory ”), which is the territory in which the Company does business and the Executive will provide services to the Company, Executive will not directly or indirectly:
(A) engage in a Competitive Business;
(B) enter the employ of, or render any services to, any person or entity (or any division of any person or entity) who or which engages in a Competitive Business;
(C) acquire a financial interest in, or otherwise become actively involved with, any Competitive Business, directly or indirectly, as an individual, partner, shareholder, officer, director, principal, agent, trustee or consultant; or
(D) interfere with, or attempt to interfere with, business relationships (whether formed before, on or after the date of this Agreement) between the Company or any of its affiliates and customers, clients, suppliers, partners, members or investors of the Company or any of its affiliates.
(iii) For purposes of this Agreement, “ Competitive Business ” means the development, manufacture, license, sale or provision of agricultural products or services and any other business in which the Company or any of its affiliates engaged while the Executive was employed by the Company.
(iv) Notwithstanding anything to the contrary in this Agreement, Executive may, directly or indirectly, own, solely as a passive investment, securities of any person engaged in a Competitive Business which is publicly traded on a national or regional stock exchange or on the over-the-counter market if Executive (i) is not a controlling person of, or a member of a Group which controls, such person and (ii) does not, directly or indirectly, own 5% or more of any class of securities of such person.
(v) During the Restricted Period, Executive will not, whether on Executive’s own behalf or on behalf of or in conjunction with any person, company, business entity or other organization whatsoever, directly or indirectly:
(A) solicit or encourage any employee of the Company or any of its affiliates to leave the employment of the Company or such affiliate; or
(B) hire any employee who was employed by the Company or any of its affiliates as of the date of Executive’s termination of employment with the Company or thereafter, or who left the employment of the Company or any of its affiliates coincident with, or within six months prior to or after, the termination of Executive’s employment with the Company.
(vi) During the Restricted Period, Executive will not, directly or indirectly, solicit or encourage to cease to work with the Company any individual consultant then under contract with the Company or any of its affiliates.
b. The parties agree that the Restricted Period shall be tolled during the pendency of any litigation or arbitration relating to the interpretation or enforcement of the covenants set forth in this Section 8.
c. It is expressly understood and agreed that although Executive and the Company consider the restrictions contained in this Section 8 to be reasonable, if a final judicial determination is made by a court of competent jurisdiction that the time or territory or any other restriction contained in this Agreement is an unenforceable restriction against Executive, the provisions of this Agreement shall not be rendered void but shall be deemed amended to apply as to such maximum time and territory and to such maximum extent as such court may judicially determine or indicate to be enforceable. Alternatively, if any court of competent jurisdiction finds that any restriction contained in this Agreement is unenforceable, and such restriction cannot be amended so as to make it enforceable, such finding shall not affect the enforceability of any of the other restrictions contained herein.
9. Confidentiality; Inventions .
a. Confidentiality . Commencing on the date hereof and continuing during the Employment Term and thereafter, Executive will not disclose or use for Executive’s own benefit or purposes or the benefit or purposes of any other person, firm, partnership, joint venture, association, corporation or other business organization, entity or enterprise other than the Company, any trade secrets, or other confidential information or data of the Company (or any of its affiliates) relating to the Company’s (or any such affiliate’s) customers, development programs, costs, marketing, trading, investment, sales activities, promotion, credit and financial data, manufacturing processes, financing methods, plans, or the business and affairs of the Company (or any such affiliate) generally; provided that the foregoing shall not apply to information which is not unique to the Company or which is generally known to the industry or the public other than as a result of Executive’s breach of this covenant. Except as required by law, Executive will not disclose to anyone, other than her immediate family, legal or financial advisors or any subsequent employer, the contents of this Agreement. Executive agrees that upon termination of Executive’s employment with the Company for any reason, she will return to the Company immediately all memoranda, books, papers, plans, information, letters and other data, and all copies thereof or therefrom, in any way relating to the business of the Company and its affiliates, except that she may retain personal notes, notebooks and diaries and personally owned books, reference material or information of a similar nature, that do not contain confidential information of the type described in the preceding sentence of this section. Executive further agrees that she will not retain or use for Executive’s account at any time any trade names, trademark or other proprietary business designation used or owned in connection with the business of the Company and its affiliates.
b. Ownership of Inventions . Executive agrees that Executive will promptly make full written disclosure to the Company, and hereby assigns to the Company, or its designee, all of Executive’s right, title, and interest in and to any and all creations, inventions or developments, whether or not patentable, which Executive may solely or jointly conceive or develop or reduce to practice, during the period of time Executive is in the employ of the Company (collectively referred to as “the Company Inventions”), other than (and the Company Inventions shall not include) any such creations, inventions or developments which demonstrably bear no relationship whatsoever to the business of the Company, or the application of technologies, ideas, or processes directly or indirectly related to the business of the Company. For the avoidance of doubt, the Company Inventions shall include any creations, inventions or developments that relate directly or indirectly to a Competitive Business. Executive further acknowledges that all original works of authorship which are created or contributed to by Executive (solely or jointly with others) within the scope of and during the period of Executive’s employment with the Company (“the Company Copyrights”) are to be deemed “works made for hire,” as that term is defined in the United States Copyright Act, and the copyright and all intellectual property rights therein shall be the sole property of the Company. To the extent any of such works are deemed not to be “works made for hire,” Executive hereby assigns the copyright and all other intellectual property rights in such works to the Company.
c. Contracts with the United States . Executive agrees to execute any licenses or assignments of the Company Inventions or the Company Copyrights as required by any contract between the Company and the United States or any of its agencies.
d. Further Assurances . Executive covenants to take all requested actions and execute all requested documents to assist the Company, or its designee, at the Company’s expense, in every way; consistent with applicable law, (1) to secure the Company’s above rights in the Company Inventions and any of the Company’s Copyrights, patents, mask work rights or other intellectual property rights relating thereto in any and all countries, and (2) to pursue any patents or registrations with respect thereto. This covenant shall survive the termination of this Agreement. If the Company is unable for any reason, after reasonable efforts, to secure Executive’s signature on any document for this purpose, then Executive hereby irrevocably designates and appoints the Company and its duly authorized officers and agents as Executive’s agent and attorney in fact, for the limited purpose of acting for and in Executive’s behalf and stead to execute such documents and to do all other lawfully permitted acts in connection with the execution of such documents.

e. Executive’s Rights Under Defend Trade Secrets Act . Executive is hereby notified in accordance with the Defend Trade Secrets Act of 2016 that she will not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that: (a) is made (i) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (b) is made in a complaint or other document that is filed under seal in a lawsuit or other proceeding. Executive is further notified that if she files a lawsuit for retaliation by an employer for reporting a suspected violation of law, she may disclose the employer’s trade secrets to her attorney and use the trade secret information in the court proceeding if she: (x) files any document containing the trade secret under seal; and (y) does not disclose the trade secret, except pursuant to court order.
10. Specific Performance . Executive acknowledges and agrees that the Company’s remedies at law for a breach or threatened breach of any of the provisions of Sections 8 and 9 would be inadequate and, in recognition of this fact, Executive agrees that, in the event of such a breach or threatened breach, in addition to any remedies at law, the Company, without posting any bond, shall be entitled to obtain equitable relief in the form of specific performance, temporary restraining order, temporary or permanent injunction or any other equitable remedy which may then be available and in the event of a breach of Sections 8 and 9 shall be entitled to cease making any payments or providing any benefit otherwise required by this Agreement.
11. Miscellaneous .
a. Governing Law . This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without regard to conflicts of laws principles thereof. The parties agree to litigate any claims or disputes between them or between Executive and any affiliate or employee of the Company, including any dispute arising under or related to this Agreement, Executive’s employment or termination of employment, Executive’s compensation or benefits, and any other dispute between the parties, exclusively in the state or federal courts located in the state of Executive’s primary place of business; provided, however, that the Company may initiate a lawsuit in another state to the extent the Company deems it necessary or desirable to enjoin a breach of this Agreement by Executive. The parties hereby waive any objection to the personal jurisdiction or venue of the state and federal courts located in the state of Executive’s primary place of business or in any other state in which a lawsuit is initiated by the Company pursuant to the immediately preceding sentence, hereby submit to the personal jurisdiction and venue of such courts, and waive the defense of inconvenient forum and/or lack of personal jurisdiction.
b. Entire Agreement/Amendments . Except for the documents related to the Company and its affiliates’ equity incentive plans, this Agreement contains the entire understanding of the parties with respect to the employment of Executive by the Company, and there are no restrictions, agreements, promises, warranties, covenants or undertakings between the parties with respect to the subject matter herein other than those expressly set forth herein. This Agreement may not be altered, modified, or amended except by a written instrument signed by the parties hereto.
c. No Waiver . The failure of a party to insist upon strict adherence to any term of this Agreement on any occasion shall not be considered a waiver of such party’s rights or deprive such party of the right thereafter to insist upon strict adherence to that term or any other term of this Agreement.
d. Severability . In the event that any one or more of the provisions of this Agreement shall be or become invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions of this Agreement shall not be affected thereby.

e. Assignment . This Agreement shall not be assignable by Executive. This Agreement may be assigned by the Company to a person or entity which is an affiliate or a successor in interest to substantially all of the business operations of the Company. Upon such assignment, the rights and obligations of the Company hereunder shall become the rights and obligations of such affiliate or successor person or entity.
f. No Mitigation, No Offset . Executive will not be required to mitigate the amount of any payment contemplated by Section 7, nor will any such payment be reduced by any earnings Executive may receive from any other source. The Company’s obligation to make the payments provided for in this Agreement and otherwise to perform its obligations hereunder shall not be affected by any set- off, counterclaim, recoupment, defense or other claim, right or action which the Company may have against the Executive or others.
g. Successors; Binding Agreement . This Agreement shall inure to the benefit of and be binding upon personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees.
h. Notice . For the purpose of this Agreement, notices and all other communications provided for in the Agreement shall be in writing and shall be deemed to have been duly given when delivered by hand or overnight courier or three days after it has been mailed by United States registered mail, return receipt requested, postage prepaid, addressed to the respective addresses set forth below, or to such other address as either party may have furnished to the other in writing in accordance herewith, except that notice of change of address shall be effective only upon receipt.
If to the Company:

One Washington Square
510-530 Walnut Street, Suite 1350
Philadelphia, PA 19106
Attention: General Counsel
If to Executive:     
Executive’s address as reflected on the payroll records of the Company.
i. Executive Representation . Executive hereby represents to the Company that the execution and delivery of this Agreement by Executive and the Company and the performance by Executive of Executive’s duties hereunder shall not constitute a breach of, or otherwise contravene, the terms of any employment agreement or other agreement or policy to which Executive is a party or otherwise bound.
j. Cooperation . Following termination of Executive’s employment with the Company, Executive shall provide her reasonable cooperation in connection with any action or proceeding (or any appeal from any action or proceeding) which relates to events occurring during Executive’s employment hereunder and the Company agrees that it shall promptly reimburse Executive for her reasonable and documented expenses in connection with her rendering assistance and/or cooperation under this Section 11(j) upon her presentation of documentation for such expenses. This provision shall survive any termination of this Agreement.
k. Withholding Taxes . The Company may withhold from any amounts payable under this Agreement such Federal, state and local taxes as may be required to be withheld pursuant to any applicable law or regulation.
l. Counterparts . This Agreement may be signed in counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument.
m. Insurance . Notwithstanding anything to the contrary herein:
(i) All rights Executive has to indemnification as a director, officer or fiduciary pursuant to any agreement, applicable statue, Company bylaws or articles of organization as in effect from time to time shall not be impacted by the provisions of this Agreement and all such rights, if any, shall survive the termination and/or expiration of this Agreement and/or the termination of Executive’s employment with the Company; and
(ii) So long as Executive is employed by the Company, and for a period of six (6) years following Executive’s termination of employment, the Company agrees to purchase and maintain insurance for Executive’s benefit, covering director, officer and fiduciary liability on the same basis as active directors, officers and/or fiduciaries, as applicable, of the Company.
n. Section 409A . The intent of the parties is that payments and benefits under this Agreement comply with or are exempt from Section 409A and this Agreement shall be interpreted and construed in a manner that establishes an exemption from (or compliance with) the requirements of Section 409A. Any terms of this Agreement that are undefined or ambiguous shall be interpreted in a manner that complies with Section 409A to the extent necessary to comply with Section 409A. Notwithstanding anything herein to the contrary, (i) if, on the date of termination, the Executive is a “specified employee” as defined in Section 409A, and the deferral of the commencement of any payments or benefits otherwise payable hereunder as a result of such termination of employment is necessary in order to prevent any accelerated or additional tax under Section 409A, then the Company will defer the commencement of the payment of any such payments or benefits hereunder (without any reduction in such payments or benefits ultimately paid or provided to the Executive) until the date that is the first business day of the seventh month following the date of termination (or the earliest date as is permitted under Section 409A), and (ii) if any other payments of money or other benefits due to the Executive hereunder could cause the application of an accelerated or additional tax under Section 409A, such payments or other benefits shall be deferred if deferral will make such payment or other benefits compliant under Section 409A, or otherwise such payment or other benefits shall be restructured, to the extent possible, in a manner, determined by the Company, that preserves the economic benefit and original intent thereof but does not cause such an accelerated or additional tax. Notwithstanding anything to the contrary herein, to the extent required by Section 409A, a termination of employment shall not be deemed to have occurred for purposes of any provision of this Agreement providing for the payment of amounts or benefits upon or following a termination of employment unless such termination is also a “separation from service” within the meaning of Section 409A and, for purposes of any such provision of this Agreement, references to a “termination,” “termination of employment” or like terms shall mean separation from service. Notwithstanding anything to the contrary herein, except to the extent any expense, reimbursement or in-kind benefit provided pursuant to this Agreement does not constitute a “deferral of compensation” within the meaning of Section 409A (1) the amount of expenses eligible for reimbursement or in-kind benefits provided to the Executive during any calendar year will not affect the amount of expenses eligible for reimbursement or in-kind benefits provided to the Executive in any other calendar year, (2) the reimbursements for expenses for which the Executive is entitled to be reimbursed shall be made on or before the last day of the calendar year following the calendar year in which the applicable expense is incurred, and (3) the right to payment or reimbursement or in-kind benefits hereunder may not be liquidated or exchanged for any other benefit. Each payment made under this Agreement shall be treated as a separate payment and the right to a series of installment payments under this Agreement is to be treated as a right to a series of separate payments. Notwithstanding the foregoing, the Company does not make any representation to Executive that the payments or benefits provided under this Agreement are exempt from, or satisfy, the requirements of Section 409A, and the Company shall have no liability or other obligation to indemnify or hold harmless Executive or any beneficiary of Executive for any tax, additional tax, interest or penalties that Executive or any beneficiary of Executive may incur in the event that any provision of this Agreement, or any amendment or modification thereof, or any other action taken with respect thereto, is deemed to violate any of the requirements of Section 409A.

o. Costs and Expenses . If any action or proceeding is brought by either party hereto seeking to collect any damages resulting from, or the injunction of any action constituting, a breach of any of the terms or provisions of this Agreement, then the non-prevailing party in the action or proceeding shall pay all reasonable costs and attorneys’ fees of the prevailing party.     

p. No Drafting Party . The Executive acknowledges that she has had an opportunity to negotiate any and all of these provisions and no rule of construction shall be used that would interpret any provision in favor of or against a party on the basis of who drafted this Agreement.

q.      Jury Trial Waiver . TO THE MAXIMUM EXTENT PERMITTED BY LAW, EACH PARTY HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY PROCEEDING (WHETHER BASED IN CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATING TO THIS AGREEMENT OR EXECUTIVE’S EMPLOYMENT BY THE COMPANY.

*****

IN WITNESS WHEREOF, the parties hereto have duly executed this Agreement as of the day and year first above written.






 
AGROFRESH SOLUTIONS, INC.
 
 
 
By:
/s/ Nance K. Dicciani
 
 
By: Nance K. Dicciani
 
 
Title: Office of the Chair
 
 
 
 
By:
/s/ Katherine Harper
 
 
By: Katherine Harper
 
 
 












AgroFresh Announces CFO Change; Names Katherine Harper as New CFO

PHILADELPHIA, Sept. 26, 2016- AgroFresh Solutions, Inc. (NASDAQ: AGFS), a global leader in produce freshness solutions, t oday announced that chief financial officer Margo Loebl will be leaving the company to pursue other professional interests. She will be replaced by Katherine Harper, a highly experienced financial professional and business leader whose 30-year career has spanned several global public companies. Most recently, Ms. Harper was the CFO of Tronox, a global leader in the mining and production of inorganic minerals and chemicals.

“We are delighted to have someone of Katherine’s extensive public company experience join AgroFresh,” said Dr. Nance K. Dicciani, chair of the board of AgroFresh and interim co-chief executive officer. “Her track record of transformational leadership, with an emphasis on global operations, cost management and forecasting, as well as strategic planning and execution are the right fit for AgroFresh and our growth priorities.”

“We are grateful to Margo for her financial leadership as AgroFresh has transitioned and grown as a public company, including establishing the systems and processes needed for a newly formed company,” Dr. Dicciani added. “We wish her the best as she pursues new opportunities.”

While at Tronox, Ms. Harper led various financial initiatives to improve cash generation, loan terms and capital allocation, in addition to managing the financing of a major acquisition for the company. Prior to joining Tronox, she served as a Product Group Chief Financial and Business Development Officer as well as held a broad range of senior financial positions within the Rio Tinto Group, a global diversified mining and resources group. Her early career spanned financial positions of increasing responsibility for such organizations as Gulbrandsen Group, General Chemical Corporation, Security Bureau and Westinghouse Electric Corporation.

Ms. Harper holds a Bachelor’s degree in Industrial Management and a Master’s in Business Administration, both from Carnegie-Mellon University. She will join AgroFresh effective October 3.

 





 
About AgroFresh
 
AgroFresh Solutions, Inc. (NASDAQ: AGFS) is a global horticultural produce industry leader, providing a portfolio of innovative products and specialty services to maintain the freshness, quality and value of fresh produce and flowers. Its core products include SmartFresh , the proven post-harvest freshness protection technology for produce; Harvista , the advanced pre-harvest technology for apples and pears; RipeLock , the innovative post-harvest quality system for bananas, and LandSpring™, an innovative pre-planting application for tomatoes and peppers to reduce transplant stress. AgroFresh currently operates commercially in more than 40 countries and employs more than 170 people worldwide. For more information, visit www.AgroFresh.com.
 
Trademark of AgroFresh Inc. ©2016 AgroFresh Solutions, Inc. All rights reserved.
 
Forward-Looking Statements
 
In addition to historical information, this release may contain “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, included in this release that address activities, events or developments that the Company expects or anticipates will or may occur in the future are forward-looking statements and are identified with, but not limited to, words such as “anticipate”, “believe”, “expect”, “estimate”, “plan”, “outlook”, and “project” and other similar expressions (or the negative versions of such words or expressions). Forward-looking statements include, without limitation, all statements regarding  the Company’s possible or assumed future results of operations, including all statements regarding anticipated future growth, adoption of the Company’s products, business strategies, competitive position, industry environment, potential growth opportunities and the effects of regulation. These statements are based on management’s current expectations and beliefs, as well as a number of assumptions concerning future events. Such forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company’s management’s control that could cause actual results to differ materially from the results discussed in the forward-looking statements. These risks include, without limitation, the risk of increased competition; the ability of the business to grow and manage growth profitably; changes in applicable laws or regulations, and the possibility that the Company may be adversely affected by other economic, business, and/or competitive factors. Additional risks and uncertainties are identified and discussed in the Company’s filings with the SEC, which are available at the SEC’s website at www.sec.gov.
 
Contacts:
Donna Greiner
AgroFresh Solutions, Inc.
+1 610-244-6665 ‬‬‬‬‬‬‬‬‪ ‬‬‬‬‬‬‬‬
‬DAGreiner@agrofresh.com‬
 
Investor Relations
Max Dutcher
+1 212-850-5677 ‬‬‬‬‬‬‬‬‪ ‬‬‬‬‬‬‬‬
‬Max.Dutcher@fticonsulting.com